相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Update on the Discovery of Efflux Pump Inhibitors against Critical Priority Gram-Negative Bacteria
Nina Compagne et al.
ANTIBIOTICS-BASEL (2023)
Discovery of AcrAB-TolC pump inhibitors: Virtual screening and molecular dynamics simulation approach
Thien-Vy Phan et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)
Discovery of small molecular inhibitors for interleukin-33/ST2 protein-protein interaction: a virtual screening, molecular dynamics simulations and binding free energy calculations
Tan Thanh Mai et al.
MOLECULAR DIVERSITY (2022)
Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
Alaa Shafie et al.
PHARMACEUTICS (2021)
Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules
Angeliki P. Kourounakis et al.
MEDICINAL RESEARCH REVIEWS (2020)
AcrB: a mean, keen, drug efflux machine
Jessica Kobylka et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2020)
Structure-based discovery of interleukin-33 inhibitors: a pharmacophore modelling, molecular docking, and molecular dynamics simulation approach
M. -T. Le et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2020)
Efflux pump inhibitors of clinically relevant multidrug resistant bacteria
Andraz Lamut et al.
MEDICINAL RESEARCH REVIEWS (2019)
RND transporters in the living world
Hiroshi Nikaido
RESEARCH IN MICROBIOLOGY (2018)
Understanding antibiotic resistance via outer membrane permeability
Ishan Ghai et al.
INFECTION AND DRUG RESISTANCE (2018)
Mapping the Dynamic Functions and Structural Features of AcrB Efflux Pump Transporter Using Accelerated Molecular Dynamics Simulations
Shirin Jamshidi et al.
SCIENTIFIC REPORTS (2018)
Simultaneous determination of newly developed antiviral agents in pharmaceutical formulations by HPLC-DAD
Nourah Zoman Al-Zoman et al.
CHEMISTRY CENTRAL JOURNAL (2017)
Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds
Trieu-Du Ngo et al.
MOLECULAR DIVERSITY (2016)
Enhancement of Antibiotic Activity against Multidrug-Resistant Bacteria by the Efflux Pump Inhibitor 3,4-Dibromopyrrole-2,5-dione Isolated from a Pseudoalteromonas sp.
Kristen E. Whalen et al.
JOURNAL OF NATURAL PRODUCTS (2015)
Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli
Timothy J. Opperman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Molecular Mechanism of MBX2319 Inhibition of Escherichia coli AcrB Multidrug Efflux Pump and Comparison with Other Inhibitors
Attilio V. Vargiu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance
Jessica M. A. Blair et al.
FUTURE MICROBIOLOGY (2014)
A Simple Method To Calculate the Temperature Dependence of the Gibbs Energy and Chemical Equilibrium Constants
Francisco M. Vargas
JOURNAL OF CHEMICAL EDUCATION (2014)
Structural basis for the inhibition of bacterial multidrug exporters
Ryosuke Nakashima et al.
NATURE (2013)
Outer membrane permeability and antibiotic resistance
Anne H. Delcour
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Imidazole-4,5-dicarboxamide derivatives with antiproliferative activity against HL-60 cells
EM Perchellet et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps
HA Bohnert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
分享论文
